Christopher Rowe

1.4k total citations
47 papers, 1.0k citations indexed

About

Christopher Rowe is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christopher Rowe has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 27 papers in Epidemiology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christopher Rowe's work include Opioid Use Disorder Treatment (26 papers), Substance Abuse Treatment and Outcomes (16 papers) and HIV, Drug Use, Sexual Risk (16 papers). Christopher Rowe is often cited by papers focused on Opioid Use Disorder Treatment (26 papers), Substance Abuse Treatment and Outcomes (16 papers) and HIV, Drug Use, Sexual Risk (16 papers). Christopher Rowe collaborates with scholars based in United States, Australia and Canada. Christopher Rowe's co-authors include Phillip O. Coffin, Glenn‐Milo Santos, Emily Behar, Eric Vittinghoff, Eliza Wheeler, Diana Coffa, Caitlin Turner, Peter J. Davidson, Margaret M. Faul and Elise D. Riley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Christopher Rowe

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Rowe United States 19 713 477 223 186 177 47 1.0k
Keith Ahamad Canada 15 659 0.9× 508 1.1× 167 0.7× 84 0.5× 175 1.0× 41 932
Rebecca McDonald United Kingdom 15 779 1.1× 485 1.0× 190 0.9× 227 1.2× 177 1.0× 55 1.0k
Shane R. Mueller United States 16 754 1.1× 422 0.9× 312 1.4× 153 0.8× 179 1.0× 26 1.0k
Herschel Smith United States 6 757 1.1× 341 0.7× 219 1.0× 185 1.0× 236 1.3× 9 1.0k
Seonaid Nolan Canada 19 823 1.2× 720 1.5× 185 0.8× 109 0.6× 201 1.1× 67 1.3k
Ján Klimas Ireland 19 736 1.0× 649 1.4× 149 0.7× 93 0.5× 176 1.0× 85 1.2k
Soraya Mayet United Kingdom 15 657 0.9× 564 1.2× 71 0.3× 108 0.6× 217 1.2× 25 984
Sharon Stancliff United States 15 584 0.8× 551 1.2× 70 0.3× 101 0.5× 153 0.9× 18 845
S. Geoff Severtson United States 8 830 1.2× 277 0.6× 399 1.8× 166 0.9× 293 1.7× 17 1.1k
R Saitz United States 7 392 0.5× 319 0.7× 172 0.8× 118 0.6× 121 0.7× 11 833

Countries citing papers authored by Christopher Rowe

Since Specialization
Citations

This map shows the geographic impact of Christopher Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Rowe more than expected).

Fields of papers citing papers by Christopher Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Rowe. The network helps show where Christopher Rowe may publish in the future.

Co-authorship network of co-authors of Christopher Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Rowe. A scholar is included among the top collaborators of Christopher Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Rowe. Christopher Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Arthur Robin, et al.. (2024). Use of in-network insurance benefits is critical for improving retention in telehealth-based buprenorphine treatment. Health Affairs Scholar. 2(3). qxae009–qxae009.
2.
Rowe, Christopher, Alan Hubbard, & Jennifer Ahern. (2023). California’s Public Safety Realignment Act and prisoner mortality. PLoS ONE. 18(4). e0284609–e0284609.
3.
4.
Rowe, Christopher, et al.. (2022). Engagement in HIV care and viral suppression following changes in long-term opioid therapy for treatment for chronic pain. AIDS and Behavior. 26(10). 3220–3230. 1 indexed citations
5.
Rowe, Christopher, et al.. (2021). Evaluating the Effects of Opioid Prescribing Policies on Patient Outcomes in a Safety-net Primary Care Clinic. Journal of General Internal Medicine. 37(1). 117–124. 3 indexed citations
6.
7.
Suen, Leslie W., Vanessa McMahan, Christopher Rowe, et al.. (2021). Factors Associated with Pain Treatment Satisfaction Among Patients with Chronic Non-Cancer Pain and Substance Use. The Journal of the American Board of Family Medicine. 34(6). 1082–1095. 7 indexed citations
8.
Rowe, Christopher, et al.. (2021). Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge. Journal of Addiction Medicine. 16(2). 169–176. 15 indexed citations
9.
Rowe, Christopher, Jennifer Ahern, Alan Hubbard, & Phillip O. Coffin. (2021). Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program. Journal of Substance Abuse Treatment. 132. 108452–108452. 9 indexed citations
10.
Coffin, Phillip O., et al.. (2020). Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain. PLoS ONE. 15(5). e0232538–e0232538. 50 indexed citations
11.
Rowe, Christopher, et al.. (2019). Drug overdose mortality among residents of single room occupancy buildings in San Francisco, California, 2010–2017. Drug and Alcohol Dependence. 204. 107571–107571. 21 indexed citations
12.
Rowe, Christopher, Eliza Wheeler, Eric Vittinghoff, et al.. (2018). Quantity fluctuations of illicitly used opioids and overdose risk. International Journal of Drug Policy. 58. 64–70. 7 indexed citations
13.
Rowe, Christopher, Eliza Wheeler, T. Stephen Jones, Clement Yeh, & Phillip O. Coffin. (2018). Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015. Journal of Urban Health. 96(1). 6–11. 20 indexed citations
14.
Turner, Caitlin, et al.. (2018). Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005–2015. Drug and Alcohol Dependence. 185. 305–312. 29 indexed citations
15.
Santos, Glenn‐Milo, Christopher Rowe, Jaclyn Hern, et al.. (2018). Prevalence and correlates of hazardous alcohol consumption and binge drinking among men who have sex with men (MSM) in San Francisco. PLoS ONE. 13(8). e0202170–e0202170. 24 indexed citations
16.
Hurstak, Emily, Christopher Rowe, Caitlin Turner, et al.. (2018). Using medical examiner case narratives to improve opioid overdose surveillance. International Journal of Drug Policy. 54. 35–42. 17 indexed citations
17.
Behar, Emily, Christopher Rowe, Glenn‐Milo Santos, Sheigla Murphy, & Phillip O. Coffin. (2016). Primary Care Patient Experience with Naloxone Prescription. The Annals of Family Medicine. 14(5). 431–436. 31 indexed citations
18.
Santos, Glenn‐Milo, Phillip O. Coffin, Tim Matheson, et al.. (2015). Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. 72(1). 21–30. 26 indexed citations
19.
Rowe, Christopher, Glenn‐Milo Santos, Emily Behar, & Phillip O. Coffin. (2015). Correlates of overdose risk perception among illicit opioid users. Drug and Alcohol Dependence. 159. 234–239. 43 indexed citations
20.
Behar, Emily, Glenn‐Milo Santos, Eliza Wheeler, Christopher Rowe, & Phillip O. Coffin. (2014). Brief overdose education is sufficient for naloxone distribution to opioid users. Drug and Alcohol Dependence. 148. 209–212. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Ahamad Breakdown of academic impact, for papers by Rebecca McDonald Breakdown of academic impact, for papers by Shane R. Mueller Breakdown of academic impact, for papers by Herschel Smith Breakdown of academic impact, for papers by Seonaid Nolan Breakdown of academic impact, for papers by Ján Klimas Breakdown of academic impact, for papers by Soraya Mayet Breakdown of academic impact, for papers by Sharon Stancliff Breakdown of academic impact, for papers by S. Geoff Severtson Breakdown of academic impact, for papers by R Saitz
Rankless by CCL
2026